The Japan breast augmentation market is valued at approximately US$131.14 million as of 2024 and is expected to reach approximately US$227.43 million by 2033, with a CAGR of approximately 7.10% forecast for 2025–2033. Breast implants are leading the market, while the adoption of minimally invasive techniques and new products is also driving growth.
The Japan breast augmentation market is on an expansionary trend, with a market size of approximately US$131.14 million in 2024 and a CAGR of 7.10% forecast for 2025–2033. The market is expected to reach approximately US$227.43 million by 2033. It comprises two major procedures, implants and fat-grafting breast augmentation, with breast implants expected to remain the leading segment.
Growth drivers include the growing social acceptance of aesthetic medicine and technological innovation. In particular, new technologies such as gummy bear implants and surface-textured implants are making it easier to achieve a natural appearance. The more natural feel and appearance that silicone-based implants can provide compared with saline implants are also valued and align with Japanese consumers’ preference for natural-looking results.
The expansion of the supply network is also supporting the market. Following Sientra’s approval in Japan for its OPUS series, a supply structure has been established to target distribution to more than 2,000 hospitals and clinics through local partners. Key companies in the competitive landscape include Establishment Labs, AbbVie, Johnson & Johnson and GC Aesthetics.
Meanwhile, the risk of complications and concerns related to complications, as well as the risks of implant rupture, silent rupture and infection, have been identified as factors restraining market growth. Progression of capsular contracture can cause breast hardening and changes in shape, making postoperative monitoring and the provision of information important.
The report comprises 176 pages, more than 60 tables and more than 50 figures and charts. In addition to analyzing the size and segments of the breast augmentation market, it covers a broad range of factors, including new technologies, clinical trials, market trends, regulation and reimbursement.